Your trusted destination for CME, CPD & Medical Education across the Middle East.
Taibah University College of Medicine
Prof. Ahmad M. Tarawah is a pioneering Saudi professor of pediatric hematology, senior consultant hematologist, clinical researcher, and public health advocate who has dedicated over three decades to transforming hereditary blood disease management, pediatric anemia care, and transfusion safety across the Kingdom of Saudi Arabia and the Arabian Gulf. He earned his Doctor of Medicine (MD) degree with distinguished academic honors, followed by rigorous postgraduate residency training in pediatrics and child health. Driven to address the heavy burden of hereditary blood disorders in the region, he completed subspecialty clinical fellowship training in pediatric hematology and oncology, gaining Fellowships with the Royal College of Physicians (FRCP) and the American College of Physicians (FACP).
Holding senior academic and clinical leadership roles, Prof. Tarawah serves as Professor of Pediatric Hematology at Taibah University College of Medicine while practicing as Senior Consultant Hematologist at the Maternity and Children’s Hospital (MCH) in Madinah. His specialized clinical scope encompasses non-malignant classical hematology,including sickle cell disease (SCD), beta-thalassemia major and intermedia, G6PD deficiency, immune thrombocytopenia (ITP), aplastic anemia, hemophilia, and rare coagulation factor deficiencies.
Throughout his distinguished career in clinical medicine, Prof. Tarawah has been a primary force behind establishing dedicated tertiary care infrastructure for patients with hereditary blood diseases. He founded and directed specialized comprehensive care centers in Madinah, creating integrated clinical networks that combine acute pain crisis management,outpatient blood transfusion units, specialized iron overload monitoring, and genetic counseling under a unified clinical framework.
A central milestone of Prof. Tarawah’s professional leadership has been advocating for early, universal hydroxyurea therapy and tailored iron chelation regimens in pediatric and adult hemoglobinopathy patients. Through his clinical trial directorships and regional guideline publications, healthcare centers across Saudi Arabia have adopted standardized protocols that significantly reduce vaso-occlusive pain crises, acute chest syndrome episodes, and transfusion-induced organ toxicity.
In addition to his bedside hospital practice and department chair duties, Prof. Tarawah is a celebrated master teacher,university lecturer, and clinical supervisor. He actively trains pediatric residents, hematology fellows, and primary care physicians at Taibah University and Ministry of Health hospitals, directing accredited continuous medical education (CME) seminars, hemoglobinopathy diagnostic workshops, and clinical case conferences. His teaching philosophy emphasizes rigorous clinical logic, holistic family-centered care, and early screening.
Prof. Tarawah is an exceptionally prolific physician-scientist who has authored over 90 peer-reviewed scientific publications, clinical trial reports, and national health monographs in leading medical journals, including Pediatric Blood & Cancer, Hemoglobin, British Journal of Haematology, and Journal of Pediatric Hematology/Oncology. His extensive research portfolio focuses on evaluating the genetic epidemiology of thalassemias and sickle cell variants in the Western Region of Saudi Arabia, analyzing iron chelation compliance, evaluating long-term organ toxicity, and assessing public health outcomes of the Mandatory National Premarital Screening Program.
Beyond his university and hospital appointments, Prof. Tarawah actively serves on regional and national health councils,Ministry of Health expert advisory committees, and international hematology taskforces. He routinely represents Saudi Arabia as a plenary keynote presenter, session chair, and course director at major global congresses, including the European Hematology Association (EHA) Congresses and American Society of Hematology (ASH) Annual Meetings,advocating for equitable access to novel disease-modifying and gene-editing therapies in developing healthcare systems.
At the International Classical Hematology Conference 2026 (ICCH 2026), Prof. Ahmad M. Tarawah stands out as a core scientific keynote presenter, clinical masterclass director, and advisory committee member. Connecting consultant hematologists, clinical pathologists, pediatricians, primary care physicians, and public health strategists, he provides delegates with crucial, evidence-based strategies to optimize classical hematology pathways, implement cutting-edge therapeutic protocols, and elevate patient outcomes nationwide and across the region.

MeetingMinds Experts
MeetingMinds Experts